CDEK
← All organizations

Fixture Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Fixture Pharma

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2015

First marketed drug

Jun 15, 2020

First NDA

Jun 15, 2020

Last known activity

Jan 1, 2021

Timeline

1990s

  1. Mar 1, 1995

    Fixture Pharmaceuticals— Founded

2010s

  1. May 1, 2018

    Fixture Biotech Labs— Acquired

2020s

  1. Jun 15, 2020

    Fixturin— NDA Organization

  2. Jul 1, 2020

    Fixturin— Marketing Organization

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (2)

Details

Founded
Boston, MA, United States Mar 1, 1995
First NDA
Jun 15, 2020
Last known activity
Jan 1, 2021

Designations held

  • Priority review

Notes

Synthetic fixture organization for e2e tests.